BIOLASE closes $4.5M public offering of Series J Preferred and Warrants

BIOLASE, INC

Gross proceeds $4.5M from sale of 75,000 units at $60/unit; underwriting discounts and expenses deducted.
Each unit: one share Series J Preferred (liquidation preference $100, 20% PIK dividend) and one warrant to buy 0.5 preferred at $30.
Series J Preferred convertible to common at $3.26/share, maturity September 18, 2024.
Net proceeds will be used for working capital and general corporate purposes.
Lake Street Capital Markets and Maxim Group acted as joint bookrunners.

item 1.01 item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOLASE, INC: Filed Certificate of Designation for Series J Convertible Redeemable Preferred Stock (effective 2023-09-14).

Change: charter amendment
Effective: 2023-09-14

Exact text from the filing

On September 14, 2023, the Company filed the Certificate of Designation with the Secretary of State of the State of Delaware to establish the powers, preferences and rights of the shares of the Series J Convertible Preferred Stock and the qualifications, limitations or restrictions thereof.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIOLASE, INC entered into Underwriting Agreement with Lake Street Capital Markets, LLC and Maxim Group LLC, as representatives of the several underwriters named therein valued at $60.00 per Unit (effective 2023-09-13).

Action: entry
Agreement: underwriting
Counterparty: Lake Street Capital Markets, LLC and Maxim Group LLC, as representatives of the several underwriters named therein
Value: $60.00 per Unit
Effective: 2023-09-13

Exact text from the filing

On September 13, 2023, BIOLASE, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC and Maxim Group LLC, as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to sell to the Underwriters, in a firm commitment underwritten public offering, 75,000 units (each a “Unit” and collectively, the “Units”), with each Unit consisting of (A) one share of the Company’s Series J Convertible Redeemable Preferred Stock, par value $0.001 per share (the “Series J Convertible Preferred Stock”), and (B) one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one-half of one (0.50) share of Series J Convertible Preferred Stock, at a price to the public of $60.00 per Unit, less underwriting discounts and commissions.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-23-236981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.